Insys Therapeutics Inc (INSY) stock is down -74% Monday. INSY stock is lower by -87.23% over the last 12 months, and the average rating from Wall Street analysts is a Moderate Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives INSY stock a score of 23 out of a possible 100.
That score is chiefly influenced by a short-term technical score of 0. INSY’s score also includes a long-term technical score of 1. The fundamental score for INSY is 68. In addition to the average rating from Wall Street analysts, INSY stock has a mean target price of $7.60. This means analysts expect the stock to rise 708.51% over the next 12 months.
What’s Happening with INSY Stock Today
Insys Therapeutics Inc (INSY) stock is down -73.93% while the S&P 500 is down -2.25% as of 11:30 AM on Monday, May 13. INSY is down -$2.66 from the previous closing price of $3.60 on volume of 4,560,468 shares. Over the past year the S&P 500 has gained 3.17% while INSY is down -87.23%. INSY lost -$1.68 per share in the over the last 12 months.